Descubrimiento y exploración: misiones espaciales y astronomía, física y biología, nuevos hallazgos de investigación y lo que los científicos aprenden sobre el mundo y más allá.
El Mundo · 4 nov 2026
El telescopio Swift de la NASA reingresó sin causar daños en la atmósfera sobre el norte de Sumatra, Indonesia, tras casi 22 años de observaciones astronómicas.
BioBioChile · 4 nov 2026
El telescopio espacial Swift de la NASA reingresó sin control sobre el norte de Sumatra y se desintegró sin causar daños, según confirmó la Fuerza Espacial de EE.UU.
El Correo · 4 nov 2026
El telescopio espacial Swift de la Nasa reingresa en la atmósfera tras fallar la misión robótica de rescate diseñada para elevar su órbita.
Rochester Democrat and Chronicle · 4 nov 2026
An AHA-presented review of 28,345 FDA adverse-event reports found caffeine and stimulant products were disproportionately linked to cardiac arrest and heart attacks in adults aged 18 to 34, though causation is not proven.
Fort Collins Coloradoan · 4 nov 2026
A review of 28,345 FDA adverse-event reports found caffeinated energy drinks and supplements disproportionately linked to cardiac arrest and heart attacks in adults aged 18 to 34. The study shows association, not proven causation.
Worcester Telegram & Gazette · 4 nov 2026
An AHA-presented review of 28,345 FDA adverse-event reports found caffeinated energy drinks and supplements disproportionately linked to cardiac arrest and heart attacks in adults ages 18 to 34.
York Daily Record · 4 nov 2026
An AHA-presented review of 28,345 FDA adverse-event reports found caffeine- and stimulant-containing drinks disproportionately linked to cardiac arrest and heart attacks in ages 18 to 34.
Detroit Free Press · 4 nov 2026
An AHA-presented review of 28,345 FDA adverse-event reports found caffeine- and stimulant-containing products were disproportionately linked to serious cardiac events in adults 18 to 34, though causation is not proven.
Springfield News-Leader · 4 nov 2026
A new AHA-presented study of 28,345 FDA adverse-event reports links caffeine and stimulant products to elevated cardiac arrest and heart attack reports in adults aged 18 to 34.
Cincinnati Cincinnati Enquirer · 4 nov 2026
A study of 28,345 FDA adverse-event reports links caffeinated energy drinks and supplements to higher rates of cardiac arrest and heart attacks in adults aged 18 to 34, though causation is not proven.
Reno Gazette-Journal · 4 nov 2026
An AHA-presented review of 28,345 FDA adverse-event reports found caffeine and stimulant products were disproportionately tied to cardiac arrest and heart attacks in adults aged 18 to 34, though causation is not established.
Asheville Citizen-Times · 4 nov 2026
A study of 28,345 FDA adverse-event reports links caffeinated energy drinks and supplements to elevated rates of cardiac arrest and heart attacks among adults 18 to 34, though causation is not proven.
Fayetteville Observer · 4 nov 2026
An AHA-presented review of 28,345 FDA adverse-event reports links caffeine and stimulant products to cardiac arrest and heart attacks in adults aged 18 to 34. The study shows association, not causation.
Amarillo Globe-News · 4 nov 2026
An AHA-presented review of 28,345 FDA adverse-event reports found caffeine- and stimulant-containing products frequently mentioned in serious cardiac events among adults aged 18 to 34.
Naples Daily News · 4 nov 2026
An AHA-presented review of 28,345 FDA adverse-event reports links caffeine and stimulant products to serious cardiac events in adults aged 18 to 34. The study shows association, not causation.
Ventura County Star · 4 nov 2026
An AHA-presented study of 28,345 FDA adverse-event reports (2017-2025) found caffeine- and stimulant-containing products disproportionately linked to serious cardiac events in adults aged 18-34, though causation is not established.
Peoria Journal Star · 4 nov 2026
An AHA-presented review of 28,345 FDA adverse-event reports found caffeinated energy drinks and supplements disproportionately linked to serious cardiac events in adults aged 18 to 34. Researchers stress association, not proven causation.
TCPalm · 4 nov 2026
An AHA-presented analysis of 28,345 FDA adverse-event reports (2017-2025) found caffeine- and stimulant-containing products disproportionately linked to cardiac arrest and heart attacks in adults 18-34, though causation is not established.
Lubbock Avalanche-Journal · 4 nov 2026
A study of 28,345 FDA adverse-event reports found caffeine- and stimulant-containing energy drinks and supplements were disproportionately linked to cardiac arrest and heart attacks in adults aged 18 to 34.
The Arizona Republic · 4 nov 2026
A study of 28,345 FDA adverse-event reports found caffeine- and stimulant-containing energy drinks and supplements appear disproportionately linked to serious cardiac events in adults aged 18 to 34.
Providence Journal (Projo) · 4 nov 2026
A review of 28,345 FDA adverse-event reports found caffeine- and stimulant-containing energy drinks mentioned more often in serious cardiac events among adults 18 to 34, though causation is unproven.
South Bend Tribune · 4 nov 2026
An AHA-presented review of 28,345 FDA adverse-event reports found caffeine- and stimulant-containing energy drinks disproportionately tied to cardiac arrest and heart attacks in adults aged 18 to 34.
Google News · 4 nov 2026
A study reported by multiple outlets links energy drinks and stimulant supplements to higher risks of cardiac arrest and heart attack among young adults.
G1 · 4 nov 2026
Após derrota de republicanos nas eleições de meio de mandato, Elon Musk perdeu cerca de US$41,8 bilhões em um dia, com ações da Tesla e SpaceX em queda.